15 results match your criteria: "John Stroger Jr. Hospital of Cook County[Affiliation]"

The objective of this analysis was to describe individual and structural-level factors associated with pre-exposure prophylaxis (PrEP) use among a sample of sexual and gender minorities (SGM) at risk for HIV recruited using limited interaction strategies. SGM (N = 3330), ages 15-34, without HIV enrolled in a nationwide limited interaction cohort study from 2017 to 2020. A baseline cross-sectional single-survey design examined individual and structural-level correlates of PrEP lifetime use and current use using logistic regression.

View Article and Find Full Text PDF

Surveillance data on high school adolescent sexual activity, including teenaged pregnancy rates and incidence of sexually transmitted infections (STIs), require pediatricians and other youth providers to be competent and confident in addressing sexual and reproductive health care needs in adolescent and/or young adult populations. The American Academy of Pediatrics has published guidelines, recommendations, clinical reports, and resources on the promotion of healthy sexual development in clinical settings, encouraging sexual health assessments that are inclusive of HIV and STI testing as an integral component of comprehensive health visits. The need for a more determined effort to address sexual health as it relates to HIV specifically is evidenced by a decrease in the number of in-school youth reporting ever being tested, 15- to 24-year-olds representing 21% of new infections, and estimates that >40% of youth with HIV are undiagnosed.

View Article and Find Full Text PDF

Despite significant progress in the treatment of preterm neonates, bronchopulmonary dysplasia (BPD) continues to be a major cause of neonatal morbidity. Affected infants suffered from long-term pulmonary and nonpulmonary sequel. The pulmonary sequels include reactive airway disease and asthma during childhood and adolescence.

View Article and Find Full Text PDF

Clinical outcome measures for cutaneous lupus erythematosus.

Lupus

August 2010

Department of Medicine, Division of Dermatology, John Stroger Jr. Hospital of Cook County, Chicago, IL 60612, USA.

Cutaneous lupus erythematosus (CLE) is a clinically heterogeneous group of rare skin diseases that only rarely have been subjected to controlled clinical trials. This may have been partly due to a lack of suitable validated outcome instruments. Recently, the Food and Drug Administration (FDA) mandated that organ-specific trials for lupus erythematosus need to use a combination of different outcome measures.

View Article and Find Full Text PDF

Objectives: To describe the mycologic and clinical outcomes and factors associated with failure in Peruvian patients with AIDS-associated cryptococcal meningitis (CM) treated with amphotericin B deoxycholate (Amph B) followed by fluconazole.

Methods: Patients were treated with intravenous Amph B 0.7 mg/kg/day for 2 or 3 weeks followed by oral fluconazole 400mg/day for 7 or 8 weeks.

View Article and Find Full Text PDF

When rat omentum becomes activated by intraperitoneal injection of inert polydextran particles, these particles are rapidly surrounded by cells that express markers of adult stem cells (SDF-1alpha, CXCR4, WT-1) and of embryonic pluripotent cells (Oct-4, Nanog, SSEA-1). We have cultured such cells, because they may offer a convenient source of adult stem cells, and have found that they retain stem cell markers and produce high levels of vascular endothelial growth factor for up to ten passages. After systemic or local injection of these cultured cells into rats with acute injury of various organs, the cells specifically engraft at the injured sites.

View Article and Find Full Text PDF

Skin involvement is a frequent presenting manifestation of systemic lupus erythematosus (SLE). Cutaneous lupus erythematosus (CLE), frequently occurring without SLE, may be even more common than SLE. Until recently, clinical instruments to measure skin involvement in CLE did not exist, hampering clinical research in this field.

View Article and Find Full Text PDF

Drug-associated lymphoma and pseudolymphoma: recognition and management.

Dermatol Clin

April 2007

Department of Medicine, Division of Dermatology, John Stroger Jr. Hospital of Cook County, Administration Bldg., 1900 W Polk Street, Chicago, IL 60612, USA.

This article discusses ways to recognize and manage lymphomas and pseudolymphomas associated with drug exposure. Over the last 30 years, the classification of pseudolymphomas and lymphomas has undergone significant change, especially following the application of sophisticated immunostaining and gene rearrangement analysis. The term cutaneous pseudolymphomas (CPL) is a nonspecific term for a heterogeneous group of benign reactive T- or B-cell lymphoproliferative processes that simulate cutaneous lymphomas clinically or histologically.

View Article and Find Full Text PDF

American Society of Maxillofacial Surgeons, 1997 to 2006: another decade of excellence in education and research.

Plast Reconstr Surg

October 2006

Chicago, Ill.; Irvine and Los Angeles, Calif.; Miami, Fla.; and Indianapolis, Ind. From the Division of Plastic, Reconstructive, and Cosmetic Surgery, University of Illinois and John Stroger Jr. Hospital of Cook County; The Aesthetic and Plastic Surgery Institute, University of California, Irvine; Regional Craniofacial Services Southern California, Kaiser Permanente; Division of Plastic Surgery, DeWitt Daughtry Family Department of Surgery, University of Miami School of Medicine; and Division of Plastic Surgery, Riley Hospital for Children, Indiana University.

View Article and Find Full Text PDF

Ability of practitioners to identify solid oral dosage tablets.

Am J Health Syst Pharm

May 2006

Division of General Medicine, Department of Medicine, John Stroger Jr. Hospital of Cook County, Chicago, IL 60612, USA.

Purpose: Physicians' and pharmacists' ability to correctly identify three commonly used oral dosage forms was assessed.

Methods: A list of physicians and pharmacists was obtained from two urban teaching hospitals. A total of 100 pharmacists and physicians were randomly selected and their ability to correctly identify three commonly used tablets was tested.

View Article and Find Full Text PDF

Clinical paradox. Man versus machine.

Saudi Med J

January 2006

Division of Neonatology, John Stroger Jr. Hospital of Cook County, 1901 W Harrison St, 4th Floor, Room, 4509, Chicago, Illinois 60612, USA.

View Article and Find Full Text PDF

Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit.

Intensive Care Med

October 2005

Department of Medicine, , John Stroger Jr. Hospital of Cook County, Rush Medical College, 1900 West Polk Street, Chicago, IL 60612, USA.

Objective: As hormones are strongly associated with mortality in critically ill patients, we investigated whether mortality prediction based on the Acute Physiology and Chronic Health Evaluation (APACHE) is improved by combining this score with hormone measurements.

Design And Setting: Intensive care units in three hospitals.

Patients And Participants: 113 patients admitted to.

View Article and Find Full Text PDF

Identifying futility in a neonatal intensive care unit setting.

Saudi Med J

June 2005

Division of Neonatology, John Stroger Jr. Hospital of Cook County, 1901 W Harrison St, 4th Floor, Room 4509, Chicago, IL 60612, United States of America.

Objective: Caring for infants born with lesions that are either incompatible with life or conditions that will not allow meaningful survival is an ethical dilemma. Provision of intensive ineffective care to these infants may be labeled as "futile care" which can consume a major proportion of total hospital expenditure. We conducted the present study to look at the extent of futility in a neonatal intensive care unit (NICU) setting.

View Article and Find Full Text PDF